Your browser doesn't support javascript.
loading
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
Takashita, Emi; Kinoshita, Noriko; Yamayoshi, Seiya; Sakai-Tagawa, Yuko; Fujisaki, Seiichiro; Ito, Mutsumi; Iwatsuki-Horimoto, Kiyoko; Halfmann, Peter; Watanabe, Shinji; Maeda, Kenji; Imai, Masaki; Mitsuya, Hiroaki; Ohmagari, Norio; Takeda, Makoto; Hasegawa, Hideki; Kawaoka, Yoshihiro.
  • Takashita E; National Institute of Infectious Diseases, Tokyo, Japan.
  • Kinoshita N; National Center for Global Health and Medicine, Tokyo, Japan.
  • Yamayoshi S; University of Tokyo, Tokyo, Japan.
  • Sakai-Tagawa Y; University of Tokyo, Tokyo, Japan.
  • Fujisaki S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Ito M; University of Tokyo, Tokyo, Japan.
  • Iwatsuki-Horimoto K; University of Tokyo, Tokyo, Japan.
  • Halfmann P; University of Wisconsin-Madison, Madison, WI.
  • Watanabe S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Maeda K; National Center for Global Health and Medicine, Tokyo, Japan.
  • Imai M; University of Tokyo, Tokyo, Japan.
  • Mitsuya H; National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; National Center for Global Health and Medicine, Tokyo, Japan.
  • Takeda M; National Institute of Infectious Diseases, Tokyo, Japan.
  • Hasegawa H; National Institute of Infectious Diseases, Tokyo, Japan.
  • Kawaoka Y; University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.
N Engl J Med ; 386(15): 1475-1477, 2022 04 14.
Article en En | MEDLINE | ID: mdl-35263535
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article